BioAtla, Inc.
BCAB- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826892
No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding BioAtla, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 87 | 2 | 81 | −4 |
| Shares | 25.4M | 33.8K | 26.4M | +1.09M (+4.3%) |
| Value | $746.4M | $994.0K | $518.4M | −$227.0M (−30.4%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held BioAtla, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 297,914 | $5.85M | 1.18% |
| Two Sigma Investments, LP | 180,921 | $3.55M | 0.01% |
| Two Sigma Advisers, LP | 151,100 | $2.97M | 0.01% |
| Renaissance Technologies LLC | 70,900 | $1.39M | 0.00% |
| Citadel Advisors LLC | 42,376 | $832.0K | 0.00% |
| Qube Research & Technologies Ltd | 35,019 | $687.0K | 0.01% |
| Marshall Wace, LLP | 31,137 | $611.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 29,766 | $584.0K | 0.00% |
| Squarepoint Ops LLC | 16,866 | $331.0K | 0.00% |
| Simplex Trading, LLC | 8,553 | $167.0K | 0.01% |
| Ensign Peak Advisors, Inc | 5,160 | $101.0K | 0.00% |
| Quantbot Technologies LP | 4,300 | $84.0K | 0.01% |
| Daiwa Securities Group Inc. | 103 | $2.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 8 | $0 | 0.00% |
| Rinkey Investments | 10 | $0 | 0.00% |
Sold out (19)
Institutions that held BioAtla, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Suvretta Capital Management, LLC | 354,190 | $10.4M |
| Ikarian Capital, LLC | 196,400 | $5.78M |
| Farallon Capital Management, L.L.C. | 180,000 | $5.30M |
| Monashee Investment Management LLC | 178,600 | $5.26M |
| Point72 Asset Management, L.P. | 128,622 | $3.79M |
| EcoR1 Capital, LLC | 50,000 | $1.47M |
| Boothbay Fund Management, LLC | 25,413 | $748.0K |
| Victory Capital Management Inc | 10,627 | $313.0K |
| Dynamic Technology Lab Private Ltd | 10,160 | $299.0K |
| Schonfeld Strategic Advisors LLC | 9,372 | $276.0K |
| UBS Asset Management Americas Inc | 8,638 | $254.3K |
| Manufacturers Life Insurance Company, The | 8,337 | $245.0K |
| Jane Street Group, LLC | 8,047 | $237.0K |
| Tudor Investment Corp Et Al | 7,810 | $230.0K |
| Dowling & Yahnke LLC | 7,592 | $224.0K |
| PDT Partners, LLC | 7,480 | $220.0K |
| STRS Ohio | 3,700 | $108.0K |
| Quadrant Capital Group LLC | 1,000 | $29.0K |
| Evolution Wealth Advisors, LLC | 110 | $3.00K |
Not filed for Q4 2021 yet (2)
Institutions that held BioAtla, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 32,611 | $960.0K |
| First Mercantile Trust Co | 1,154 | $34.0K |